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Abstract
The molecular mechanisms of the development of
teratocarcinomas from stem cells are largely unknown.
To determine which genes are associated with the
transformation of these cells, we have performed
oligonucleotide microarray analysis, using Affymetrix
U74A GeneChips, on both cell cultures and tumors in
nude mice. We identified 68 genes that significantly
differed in expression between the ES cell culture and
the teratocarcinoma cell line, SCC-PSA1, and 51 genes
with statistically different expression patterns between
the ES cell tumors and the teratocarcinomas (P <
.00005). We found that there were 20 genes that had
common expression patterns in both groups. We also
examined the role of the transition from in vitro to
in vivo by comparing ES cell culture to ES cell tumor,
and teratocarcinoma cell line to teratocarcinomas. We
identified 22 genes that were upregulated in the ES cell
tumors and 42 that had a decreased expression in the
tumor (P < .0001). In comparing SCC-PSA1 to its tumor,
we identified 34 upregulated genes and 25 downregu-
lated genes (P < .001). There were only 10 genes in
common from these two lists. GenMapp search re-
vealed that several pathways, especially the cell cycle
pathway, are actively involved in the induction of
teratocarcinomas. Our results indicate that many key
development genes may play a key role in the trans-
formation of ES cells into teratocarcinoma cells.
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Introduction
Cancer is a complicated and heterogeneous disease, taking
many forms and affecting many tissues. Dysregulation of
the cell cycle is a common factor among all types of cancer.
The ability to activate alternative pathways to regain cell
cycle control, or stimulate apoptosis after some form of
cellular damage, would be a valuable way to fight cancer.
Developmental genes are strict regulators of cell cycle and
apoptosis; therefore, the genetic components of embryonic
development are potential sources of cancer phenotype res-
cue. They are responsible for the migration and differentiation
of all of the body’s cell types, as well as for the maintenance of
appropriate cell mass (i.e., apoptosis). These genes have the
potential to override the signals sent by the cancer cells’
abnormal gene expression and are therefore excellent candi-
dates for gene-based therapies.
In order to study developmental gene regulation in the
context of carcinogenesis, we have undertaken the physical
and molecular characterization of teratocarcinomas. Terato-
carcinomas are embryonic cancers that are most often found in
the sex organs of human adults, but they have been seen in
various locations throughout the body in patients. In adult
humans, spontaneous teratocarcinomas originate primarily
from germ cells, but teratocarcinomas can also form from
dysregulated stem cells, which are most frequently seen in
prenatal or newborn tumors. Characteristic morphology of
teratocarcinoma tumors includes diploid embryonic stem cells
mingled with immature tissues and highly specific, differentiat-
ed tissue (e.g., muscle, bone, teeth, etc.) [1].
The objective of this study was to determine the possible
mechanisms that dictate the tumorigenic properties of terato-
carcinomas by comparing them to their embryonic stem cell
progenitors. By using oligonucleotide array analysis, we can
observe the repercussions of carcinogenic transformation by
examining gene expression changes between the teratocarci-
noma and the embryonic stem cell control. We examined
cultures of these two cell types, as well as tumors in nude
mice, in order to elucidate the mechanisms of tumorigenic
properties of teratocarcinomas. The results from this study
have the potential to shed new light on mechanisms of carci-
nogenesis.
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Materials and Methods
Teratocarcinoma and ES Cells
The experiments described in this paper were performed
using the following cell lines and conditions. An established
murine diploid teratocarcinoma cell line, SCC-PSA1, was
obtained from the American Type Culture Collection (ATCC;
Manassas, VA). Cells were grown in DMEM media (Gibco,
Grand Island, NY) containing 10% fetal bovine serum (FBS)
(147; Gibco) and 1% penicillin/streptomycin (Gibco) at 37jC
in 5% CO2. The teratocarcinoma cells were grown on feeder
layers of STO cells (ATCC) that had been treated with
10 mg/ml mitomycin C (Sigma, St. Louis, MO) for 6 hours.
The TC1 ES cell line was obtained from the laboratory of
Michael Weinstein (Ohio State University, Columbus, OH).
The ES cells were grown on STO feeder layers in the same
conditions as described above using DMEM media contain-
ing 15% FBS, 1% penicillin/streptomycin 1% MEM nones-
sential amino acids (Gibco), 1% L-glutamine (Gibco), 500 ml
of leukemia-inhibitory factor (LIF; ESGRO, ESG1106; Chem-
icon International, Temecula, CA), and 4 ml of b-mercaptoe-
thanol (Sigma). Both the SCC-PSA1 cell line [2] and the TC1
cell line were derived from 129Sv mice.
Tumor Induction
Tumors were induced in inbred BALB/c athymic nude
mice (BABL/cAnNCrj-nu; Charles River, Wilmington, MA).
Mice, receiving 500,000 teratocarcinoma and control ES
cells, were injected with teratocarcinoma cells on the right
flank and control ES cells on their left flank. Four mice were
used in this study. Tumor latency and volume (cm3) were
monitored over a period of 45 days. At the conclusion of that
period, the mice were sacrificed and the tumors were mea-
sured and weighed. Any test animal whose tumor size
imposed too great a burden was sacrificed prior to the end
of the study.
Cytogenetics
After treatment with Colcemid at a concentration of
10 mg/ml in Hanks’ balanced salt solution (Gibco) for 30
minutes, the hypotonic solution potassium chloride (KCl) was
applied at 0.075M for 20 minutes (Sigma), followed by
the fixative Carnoy’s solution [methanol (Fisher, Fairland,
NJ):glacial acetic acid 3:1] overnight. The samples were
then dropped on clean microscope slides and stained with
Wright stain. After overnight desiccation, the cells were
examined for chromosomal abnormalities by light micros-
copy ( 40 –  100). Two cells from 10 different slides were
examined in order to determine a representative population.
RNA Amplification
Total cellular RNA was collected from each time point.
Total RNA was isolated by Trizol (Invitrogen, Carlsbad, CA)
and was cleaned up with a Qiagen RNeasy Mini kit
(QIAGEN, Valencia, CA). In vitro transcription-based RNA
amplification was then performed on each sample. cDNA
was synthesized using the T7-(dT)24 primer: 5V-GGCCAGT-
GAATTGTAATACGACT-CACTATAGGGA6GCGG-(dT)24-
3V. The cDNA was cleaned using phase-lock gel (Fisher)
phenol/chloroform extraction. After clean up, in vitro tran-
scription labeling was performed using the Enzo ‘‘Bioarray
Kit’’ (Affymetrix, Santa Clara, CA). The resulting cRNA was
cleaned up, again using the Qiagen RNeasy Mini kit.
Affymetrix GeneChips Probe Array
AffymetrixMu74Av2GeneChips, encompassingf12,000
genes and expressed sequence tags (ESTs) on one array,
were processed according to the manufacturer’s recom-
mendations. Approximately 16 probe pairs (oligonucleotides)
represent every gene or EST in a probe set. One sequence
represents the complimentary strand of the target sequence,
whereas the other has a 1-bp mismatch at the central base
pair position. This mismatch sequence serves as an internal
control for specificity of hybridization. The relative expression
is reported as the average difference of the fluorescence
intensity values between the perfect match and the mis-
match oligonucleotides, resulting in the ‘‘average difference’’
value [3,4].
Statistical Analysis
Four independent samples were collected per time point.
Stages of analysis consisted of: 1) array normalization; 2)
estimation of gene expression; and 3) statistical testing. To
make arrays comparable, raw intensity values within CEL
files were normalized by regression as follows. A pseudo-
array was produced, consisting of the median spot intensity
determined across all arrays for all spots. Each real array
was quadratically regressed against this median pseudo-
array. Resulting scaled CEL files were used to estimate gene
expression according to the full model index of Li and Wong
(LWF), which was recently shown by Lemon et al. [5] to be
superior to both the Li–Wong reduced model and Affymetrix
average difference [6]. Genes with negative expression
indexes were removed.
In order to determine expression change, a standard
Student’s t test was performed between the average values
for each group based on the analyses desired (e.g., ES cells
in culture versus induced ES cell tumor). Genes selected
for further study had a P value <.0001 or .0005, depending
on the group examined (see text). For the selected genes,
expression indexes were transformed across samples to a
N(0,1) distribution using a standard statistical Z-transform.
These values were input to the GeneCluster program and
genes were hierarchically clustered using average linkage
and correlation dissimilarity.
GenMapp
Signal transduction pathways, metabolic pathways, and
other functional groupings of genes were evaluated for
differential regulation using the visualization tool GenMAPP
(UCSF, www.genmapp.org). GenMAPP is a recently
reported tool for visualizing expression data in the context
of biologic pathways [7]. We imported the statistical results
of our data set into the program and used GenMAPP to
illustrate pathways containing differentially expressed
genes. Differential gene expression was based on ES
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tumors versus teratocarcinomas expression change (fold ±
1.5 and P V .05 as indicated by asterisk in Figure 7).
Real-Time Polymerase Chain Reaction (PCR)
Two micrograms of total RNA per sample, collected as
described above, was converted to cDNA using the Super-
Script First-Strand Synthesis system for real-time PCR (Invi-
trogen, Carlsbad, CA). The primer used to generate cDNA
was the same as that used to generate cDNA for
the oligonucleotide array assay [T7- (dT)24 primer: 5V-
GGCCAGTGAATTGTAATACGACTCACTATAGGGA
GGCGG-(dT)24-3V]. cDNA generated from each of the sam-
ples comprising one group was then pooled and real-time
PCR was performed.
The real-time PCR assay was performed using the Bio-
Rad iQ SYBR Green Super Mix kit (BioRad, Hercules, CA).
The following primers were used to amplify the genes of
in terest : CDC7 F-ACTGCAGTTTCTGGGTGCTT,
R - A GC AGGA AC T CC T C AGCA AG ; c l u s t e r i n
F-TGTGGACTGTTCAACCAACAA, R-ATTCCCTCCCAGA-
CACTCCT; disabled 2 F-GAGGAGCGGCTACCTTTACC,
R-GGTCAAACAGCTGCAACGTA; MAD2 F-GCCGAG-
TTTTTCTCATTTGG, R-CCGATTCTTCCCACTTTTCA;
MFAP2 F-GAGGAACTTCTCCGAGCTGA, R-AAAACA-
GAGGTGGTCCATGC; PEM F-AAATGGAGGAAAAGGC-
CACT, R-TTCTCCCCATCTCACTCCAC; trophoblast
glycoprotein F-CAACCTGACACACCTCGAAA, R-GGTC-
CGCATTGATTTCGTAT. One microliter of pooled cDNA
was added to a 25-ml total volume reaction mixture containing
water, iQ SYBR Green Super mix, and primers. Each real-
time assay was performed in triplicate. Data were collected
and analyzed on the BioRad iCycler version 2.033. GAPDH
(pr imers : F-TGGAGAAACCTGCCAAGTATG, R-
GTGGGTGCAGCGAACTTTAT) was used as an internal
standard. The GAPDH value, a reflection of the number of
cycles needed to reach a threshold of fluorescence, was
subtracted from the cycle value for the individual gene whose
expression was being assessed. Fold change was assessed
by dividing the microarray expression value or the real-time
expression value for the cancerous tissues by the values
generated for the age-matched control tissues. For the
calculation of the fold-change values in Figure 4, the age-
matched sample N1 was used for the control value for the
ADE sample and the age-matched sample N2 was used as
the control value for the CAR sample.
Results
In our search to better define the tumorigenic properties of
teratocarcinomas, we have characterized the properties of
teratocarcinoma cells. The basic morphology of teratocarci-
noma cells in culture is quite similar to ES cells (data not
shown), complicating the differentiation between the two cell
types. When kept in media that contains LIF and on a bed
of feeder cells, such as mitomycin C–treated STO cells, ES
cells maintain a slightly clumped distribution across the
surface of the cell culture plate and have a round shiny
appearance. This is also the case for teratocarcinoma cells,
but the addition of LIF is not necessary to maintain the
undifferentiated state. One main difference between the
two cell types is adherence. Teratocarcinoma cells are much
less adherent to the feeder cell layer than the ES cells,
making separation of teratocarcinoma cells from the feeder
layer much easier.
Although the growth of ES cells and teratocarcinoma cells
is relatively similar in vitro, growth in vivo is quite different.
Figure 1 shows the growth differences of the teratocarcino-
ma cells versus the ES cells. Three nude mice were injected
with 5  105 ES cells on the left flank and 5  105 terato-
carcinoma cells on the right flank. In Figure 1A, an in situ
picture of representative tumors from the nude mice injec-
tions is presented. In Figure 1B, the tumors from Figure 1A
have been excised and the size is shown with a metric
ruler. Figure 1C is a graph detailing the tumor weight differ-
ences between the average of the ES cell tumors and
the teratocarcinoma tumors (P < .05). It is clear from this
figure that teratocarcinoma cells grow at a much faster rate
than the ES cells.
Morphology of the two tumors was also similar to a point.
Both cell types resulted in tumors with differentiated tis-
sues, including skeletal muscle, squamous epithelium, and
vascular tissues, as seen in Figure 1, D and E. In the ES cell
benign tumors, vasculature was restricted, whereas in the
teratocarcinomas, extensive recruitment of blood vessels
was seen. The major defining characteristics of the terato-
carcinomas were the extensive areas of necrosis and fre-
quent mitotic figures, leading to the conclusion that the
teratocarcinoma tumors have metastatic capabilities. There
are also several other tissue types present in the teratocar-
cinomas, such as cartilage and glandular materials, that
were not seen in the ES cell tumors.
In order to better characterize the teratocarcinoma cell
line, SCC-PSA 1, we undertook cytogenetic analysis to
determine whether or not large chromosomal abnormalities
were responsible for the phenotypic changes seen between
the ES cells and the teratocarcinoma cells. The common kar-
yotyping method of G-banding using trypsin and Wright’s
stain (GTW) was applied to two separate cultures of the
SCC-PSA 1 cell line. Of the 20 separate metaphase spreads
identified, the normal murine diploid karyotype number of
38 autosomes and 2 sex chromosomes, in this case two
X chromosomes, were seen in each cell. Figure 2 is a rep-
resentative metaphase spread (A) and karyotype (B) of the
SCC-PSA 1 cell line. Because the computer program used to
assist in the karyotyping was designed for human karyo-
types, there are several extra numbers associated with the
figure that do not correspond to murine chromosomes.
Because there were no major chromosomal abnormalit-
ies detected in the 20 cells that were examined by karyotyp-
ing, we hypothesize that other genetic changes are
responsible for the phenotype differences between ES cells
and teratocarcinoma cells. In order to assess the genetic
changes occurring during the transition from ES cell to ter-
atocarcinoma cell, we used Affymetrix U74A GeneChips
microarrays to determine the overall gene expression
changes between both ES cell cultures and tumors, and
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Figure 1. Characterization of teratocarcinoma tumor growth referenced to ES cell tumor growth. (A) Representative tumors in situ. About 5  105 ES cells were
injected on the left flank of the mice and 5  10 5 SCC-PSA1 (teratocarcinoma) cells were injected on the right flank. (B) Resected tumors. Representative tumors
from the nude mouse experiment were resected and photographed. Centimeter ruler to the right to indicate tumor size. (C) Differential growth of the ES cell tumors
and teratocarcinomas (P < .05). The orange bar represents average teratocarcinoma growth; the blue bar represents ES cell growth. Tumor weight in grams is on
the Y-axis. (D) Hematoxylin and eosin (H&E) staining of section of resected tumors. This area demonstrates the tissue types of (1) glandular epithelium, (E)
squamous epithelium, and (y) mature skeletal tissues, which were similar in both the ES cell tumors and the teratocarcinomas. (E) H&E staining of another portion
of tissue, immature neuroepithelial rosettes, similar in both tumor types. (F) H&E–stained section from a teratocarcinoma demonstrating the areas of necrosis and
frequent mitotic figures, which is unique to the teratocarcinomas.
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teratocarcinoma cell cultures and tumors. Total RNA was
isolated fromES cell and teratocarcinoma cell cultures 2 days
after plating, as well as from flash frozen portions of the
resected nude mouse ES and teratocarcinoma tumors. Anal-
ysis of expression included a two-tailed Student’s t test as
well as fold-change detection.
In order to better understand the mechanisms of tumor-
igenesis, we examined the gene expression changes be-
tween the ES cell cultures and the teratocarcinoma cell
cultures, as well as the gene expression changes between
the ES cell tumors and the teratocarcinomas from the nude
mice study. Figure 3 contains two lists, detailing the genes
Figure 2. Karyotype analysis of SCC-PSA1 cell line. (A) Representative metaphase spread for the SCC-PSA1 cell line. Twenty separate metaphase spreads were
examined and no detectable numerical abnormalities were found. (B) Representative karyotype of SCC-PSA1 cell line. A normal karyotype of 38 autosomes and
2 sex chromosomes was seen in all 20 of the cells examined. No apparent chromosomal abnormalities were identified. Note: The computer program used to
display the karyotype is intended for human karyotypes, leading to the excess of numbers that do not correspond to any murine chromosomes.
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with a P value of less than .00005 for both of the analyses.
Figure 3A contains data for the cell culture comparisons, 68
total genes with 28 upregulated in the teratocarcinoma cell
culture and 40 genes downregulated in the teratocarcinoma
cell culture. Figure 3B contains the tumor data, displaying 31
genes upregulated in the teratocarcinoma tumor and 20
genes downregulated. There are several genes of interest
whose expression is significantly altered in the teratocarci-
noma cell cultures. Increased expression is seen in MCM 4,
a critical factor in DNA replication, as well as the c-myc–
responsive gene, JPO1. As would be expected, teratocarci-
noma-derived growth factor expression is increased, as is
the expression of the Bloom syndrome gene.
Interestingly, Ras 1 expression andGRO1 expression are
significantly decreased in the tumor cell line. We do see
decreases in the anti–proliferative factor B-cell translocation
1 and GATA-6, usually associated with lung cell differentia-
tion. Clusterin, a controversial protein found to both inhibit
and encourage apoptosis, has decreased expression as
well. Finally, HMG2, a cellular differentiation factor, is also
decreased.
Between the ES cell tumor and the teratocarcinoma, there
are also some very interesting expression changes. Both
CDC 25 and CDC 7, critical factors in cell cycle progression,
are overexpressed in the teratocarcinomas. The homologue
of the human Highly Expressed in Cancer (HEC) gene is
predictably overexpressed as well. ADAM 8, a cell adhe-
sion molecule, is significantly downregulated in the terato-
carcinoma, possibly allowing for local tissue invasion.
Calcyclin, usually seen to be upregulated in cancers such
as prostate, is decreased in the teratocarcinoma in our study.
To exclude genes whose expression changes might be
the result of the environment change (i.e., from in vitro to
in vivo), we examined the cell types in relation to each other.
Figure 4 lists the genes whose change in expression be-
tween the cell culture samples versus the tumor has a
P value of less than .0001. Figure 4A compares ES cells in
culture to the ES cell tumors induced in nude mice, and
Figure 4B compares teratocarcinoma cells in culture to the
teratocarcinoma tumors induced in nude mice.
Between the transition from in vitro to in vivo for the ES
cells (Figure 4A), we see 64 genes with significant expres-
sion changes. The 42 genes downregulated in the ES cell
tumor include the key cell cycle regulators CDC2A, CDC6,
and cyclins B1 and F. Interestingly, we also see down-
regulation of several known oncogenes: placentae and em-
bryos oncofetal gene (PEM), HEC, and GRO1. This has
interesting implications in respect to the conditions of cell
culture and its effect on the cell.
There are relatively fewer genes upregulated in the ES
cell tumor. We do see two known oncogenes upregulated in
the ES cell tumors, E26 avian leukemia oncogene 1 (Ets1)
and lung carcinomamyc-related oncogene1.Heat shock pro-
teins 2 and 40B10 are also upregulated in the ES cell tumor.
There are 59 genes with significant expression changes
found between the teratocarcinoma cell line and the terato-
carcinoma tumor (shown in Figure 4B)—34 with an in-
creased expression in the tumor and 25 downregulated in
the tumor. The BCL2-related protein A1D is upregulated
in the teratocarcinoma, as is Rho B. Hepatocellular carcino-
ma–associated antigen 112 is also upregulated in the te-
ratocarcinoma.
As was seen in the ES cell tumor, PEM is downregulated
in the teratocarcinoma. Embryonal stem cell–specific 1 is
downregulated as well, implying in the name that the terato-
carcinoma is clearly a different cell type than the ES cell from
which it is derived. Along those same lines, undifferentiated
embryonic cell transcription factor 1 also has decreased
expression in the tumor, alluding to the potential for differ-
entiation that is the hallmark of the teratocarcinoma pheno-
type in humans.
GenMapp search revealed that the cell cycle pathway is
actively involved in the development of teratocarcinomas
with changes in multiple cell cycle genes (BUB1, MAD2L1,
Cdc25A, Cdh1, CycB1, CDK1, WEE1, Cdc7, DP1, CDK4,
MCMs, and E2F5) (Figure 7). Several cellular pathways–
related genes are also found including apoptosis (cas-
pase 3, caspase 7, poly [ADP ribose] polymerase-1),
TGFb pathway (thrombospondin, Smad2, 5V-TG-3V inter-
acting factor), and Wnt pathway (wnt-4, wnt-5a).
Our microarray results clearly demonstrate the genetic
differences between embryonic stem cells and teratocarci-
nomas. In order to verify these results, we selected a subset
of genes from all of the groups analyzed and performed real-
time reverse transcription polymerase chain reaction (RT-
PCR) to assess whether or not gene expression data from
the microarrays was an accurate depiction of the transcrip-
tion taking place. Figure 5 is a graphic representation of fold
change between both the ES cell culture and teratocarcino-
ma cell culture data, and between the ES cell tumors and
teratocarcinomas induced in nude mice. Although the fold
change values for the comparisons between either group
may differ, the expression patterns seen with the real time
RT-PCR verify our microarray data.
Discussion
In this study, we have characterized the tumorigenic proper-
ties and gene expression profiles of teratocarcinomas, which
will further the understanding of teratocarcinoma develop-
ment. We began our molecular characterization of teratocar-
cinomas based on the lack of evidence supporting large
chromosomal abnormalities as a factor of tumorigenesis.
We utilized microarray technology to observe the overall
differences in gene expression that could be responsible for
the teratocarcinoma phenotype. In order to understand the
molecular processes that are contributing the most to the
transformation of the ES cell into a teratocarcinoma cell, we
have compiled a list of those geneswhose expression pattern
changes were common to both the cell cultures and the
tumors. Figure 6A is a list of genes that the analyses from
Figure 3 have in common (P < .001). There are 12 genes
whose expression is increased in both the teratocarcinoma
cell line and the teratocarcinoma, and eight genes whose
expression is decreased in both sample types. All of the
genes represented in this figure have a P value of less than
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Figure 3. Global expression changes of the transformation of teratocarcinoma cell from ES cells. (A) Cells in culture: a comparison of ESC versus TERC
(P < .00005). Red indicates expression higher than the mean value. Green indicates expression below the mean value. Black indicates a value near the mean.
Gene name is indicated to the right of the colored diagram. FC—fold change between the average expression values for the two groups being compared; Probe
ID—Affymetrix probe identification number; Pub Acc—public accession number corresponding to the gene sequence used to generate the Affymetrix probe. (B)
Tumors: a comparison of ES versus TER (P < .00005). Color scheme and labels identical to that described in Figure 4A.
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.001, so it is interesting to note that one gene, trophoblast
glycoprotein, showed a contradictory expression pattern.
Trophoblast glycoprotein expressionwas seen to increase
in the teratocarcinoma tumor compared to its expression in
the teratocarcinoma cell line. This gene plays a role in the
modulation of cell adhesion and mobility, which could explain
the change in expression between the cell line and the tumor.
The other genes in the figure play key roles in a variety
of cell cycle functions. CDC7 is critical for the initiation of
DNA replication but also plays a role in maintenance of
genomic integrity [8]. Mad2-like1 is involved in the cell
cycle checkpoint responsible for appropriate spindle attach-
ment to the centromere. Enhancer of Zeste 2 has histone
methyl transferase activity. All of these genes are upregu-
lated in both the teratocarcinoma cell line and in the tumor.
Of the downregulated genes, Clusterin stands out. Its
function is disputed but much of the evidence points to a
proapoptotic role [9,10]. Two serine protease inhibitors,
Cystatin C and Serine Proteinase Inhibitor G1, are down-
regulated as well.
In addition to the phenotypic response resulting from
molecular changes during the transformation of the ES cells
Figure 3. Continued.
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Figure 4. An examination of the expression changes associated with the transition from in vitro to in vivo. (A) The expression of genes in ES cells in culture compared
to the expression of genes in ES cell tumors induced in nudemice (P < .001). Labeling and color scheme identical to that described in (A). (B) The expression of genes
in teratocarcinoma cells in culture compared to teratocarcinomas induced in nude mice. Labeling and color scheme identical to that described in (A).
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into teratocarcinoma cells, we recognize the potential for
drastic change in gene expression during the transition from
culture to in vivo (see Figure 4). Figure 6B details those
genes whose expression changes are common between the
cell cultures and tumors of both the ES cells and the
teratocarcinomas.
There are seven genes that are downregulated in both
the ES cell and teratocarcinoma tumors. Included in the list
of genes with decreased expression after tumor induction
are genes specifically involved in the maintenance of the
embryonal nature of the cells: PEM, undifferentiated em-
bryonal cell TF 1, embryonal stem cell–specific 1, and,
Figure 4. Continued.
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surprisingly, teratocarcinoma-derived growth factor. Interest-
ingly, Disabled 2, shown to be involved in the MAPK pathway
[11] and to mediate c-fos expression and the cell growth–
regulatory function of retinoic acid in F9 embryonic stem cell–
like teratocarcinoma cells [12], is also downregulated in the
tumors. Metal response element binding transcription factor
2 and POU domain 5 transcription factor 1 are also down-
regulated in the tumors.
There are three genes that are upregulated in both
tumor types. Those genes with increased expression in
the tumors are lysozyme, microfibrillar-associated 2, and
insulin-like growth factor binding protein 7. The upregula-
tion of microfibrillar-associated 2, shown to interact with
fibrillin-1 and fibrillin-2 [13], may result from the need to
establish an anchor for growth in the host. Insulin-like
growth factor binding protein 7/mac25 has been shown to
be downregulated in liver tumorigenesis [14], but in our
system, this factor seems to have a positive growth
influence.
To identify the precise genes or pathways responsible for
teratocarcinoma induction, altered gene expression in tera-
tocarcinomas was investigated. Microarray, together with the
GenMAPP analysis, revealed that several cellular pathways
are involved in the teratocarcinoma tumorigenesis, possibly
through the interplay among cell cycle regulation, apoptosis,
G13 pathway, TGFb pathway, and Wnt pathway. GenMapp
showed that a total of 26 genes have altered with fold change
of ±1.5 in the cell cycle pathway. Out of these 26 genes, 19
have the P value V.05 (Figure 7). The expression of the
following genes in cell cycle pathway—mitotic checkpoint
serine/threonine protein kinase (BUB1), mitotic spindle as-
sembly checkpoint protein (MAD2L1), M-phase inducer
phosphatase 3 (Cdc25A), E-cadherin (Cdh1), G2/mitotic-
specific cyclin B1 (CycB1), cell division control protein 2
homolog (CDK1), Wee1-like protein kinase (WEE1), cell
division cycle 7–related protein kinase (Cdc7), transcription
factor DP-1 (DP1), cell division protein kinase 4 (CDK4),
DNA replication licensing factors (MCM2, MCM3, MCM4,
Figure 5. Real-time RT-PCR analysis of several genes of interest compared to the microarray expression analysis. ES cell tumor data (ES) are compared to
teratocarcinoma data (TER) for both microarray data (dark orange) and real-time RT-PCR (light orange). Also included are data from the ES cell culture (ESC) versus
teratocarcinoma cell culture (TERC) for both microarray data (dark blue) and real-time RT-PCR data (light blue). Gene name is on the X-axis and fold change is on the
Y-axis. Real-time PCR was performed on two samples and the value presented is the average of the two samples (with a variation of less than 10%).
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MCM5, andMCM7), and E2F5—is found to be altered in the
teratocarcinomas. For example, cell cycle proteins regulate
multiple cell type–dependent cell cycle–regulating events,
including cell cycle checkpoint enforcement and regulating
exit from mitosis and normal mitotic timing (BUB1), mitotic
checkpoint (MAD2L1), progression of the cell cycle
(CDC25A), control of cell cycle at the G2/M (mitosis) transi-
tion (CycB1, CDK1, WEE1, and Cdc7), and cell cycle pro-
gression from G1 to S phase (DP1, MCM2, MCM3, MCM5,
MCM7, and E2F5). Crosstalk of these cellular processes
may be involved in the teratocarcinoma tumorigenesis. Al-
though the exact molecular mechanism behind the develop-
ment of teratocarcinoma is still not clear, our data show that
several dysregulated cellular signaling pathways, especially
the cell cycle pathway, are important in this malignancy.
In summary, this study of teratocarcinoma tumorigenesis
has provided clues underlying the transformation of embry-
onic stem cells and has found that no gross cytogenetic
changes occurred in this type of cancer formation. We have
also presented gene expression changes specific to the
transition from in vitro to in vivo.
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